Published: April 11, 2026
Source: Yantai Hongyu Starry Biotech Co., Ltd.

For years, when people talked about API (Active Pharmaceutical Ingredient) supply, the first thought was: China is the manufacturing hub, and India is the leader in formulations. However, in recent years, this landscape is changing, and it’s becoming increasingly important for export businesses to pay close attention.

On one hand, India is continuously boosting the development of domestic API, KSM (Key Starting Material), and intermediate manufacturing capabilities. The policy support is explicit, with the PLI (Production-Linked Incentive) scheme being a typical signal. On the other hand, India’s dependence on Chinese API and related intermediates has not diminished rapidly. Instead, according to officially disclosed data, both import volume and the Chinese share have been rising in recent years. Meanwhile, China still maintains a strong position in manufacturing scale, complete industrial chain, and delivery efficiency. However, global buyers are no longer only looking at price; they are increasingly focusing on “Supply Chain Security, Compliance Capability, Delivery Stability, and Geopolitical Risk Diversification.”

Therefore, the real question is not “Will India replace China?” but rather: In this new round of global supply chain restructuring, how should Chinese API suppliers understand India’s rise and what does it mean for themselves?

I. Why has “China vs. India” become a core topic?

Many businesses have felt recently that discussions about “Make in India” are clearly increasing. However, if we only interpret this as “Will India replace China?” we are missing the point. The real change lies in the fact that buyers are redefining what constitutes a “suitable supplier.”

In the past, API procurement was a decision model based on “Price + Delivery”:

– Who offered a lower price?
– Who could deliver stably?

Today, the procurement logic is evolving to:

– Is there over-reliance on a single country?
– Does the supply chain possess resilience?
– Does the company have the ability to cooperate long-term?
– Is the information sufficiently transparent and verifiable?

👉 This implies that the selection criteria are upgrading, not simply a replacement of supply sources.

II. Why is this change occurring?

Structurally, this round of changes is the result of the superposition of three forces.

1. India is actively supplementing its upstream manufacturing capacity

In recent years, India has continued to invest in key API and intermediates through policies like the PLI scheme. The core goal is to reduce external dependence. This indicates one thing: India is no longer satisfied with being “downstream formulators” but is moving upstream.

2. China remains deeply embedded in the supply chain

Equally important is the fact that India currently still highly relies on Chinese imports for APIs and intermediates. Judging from actual trade data, this dependence has not decreased rapidly. This means:
The current reality is more like India is enhancing its capabilities, while China remains the critical upstream backbone.

3. Global buyers are restructuring their procurement logic

This is the most crucial point.
An increasing number of buyers are adopting a “China + 1” or multi-source strategy.
The reason is not that “Chinese products are not good,” but:

– Reducing supply risks
– Improving supply stability
– Diversifying geopolitical uncertainties

👉 Therefore:
India’s rise is essentially a result of the “risk diversification” logic.

III. Typical Mistakes: Four Things Chinese API Exporters Often Misjudge

Mistake 1: Misinterpreting India’s growth as China’s decline

India’s growth is a fact, but China’s advantages in manufacturing scale, complete industrial chain, and delivery capability have not been fully replaced.
👉 The two are more like structurally overlapping in competition, not a simple substitution.

Mistake 2: Still relying on “price advantage”

If the competition logic remains:
👉 Who is cheaper?
The future space will become increasingly limited. Because buyers are increasingly valuing:

– Stability
– Compliance capability
– Information transparency

Mistake 3: Only showcasing products, not capabilities

Many company websites still only feature:

– Product lists
– Brief descriptions
– A small number of parameters

But what buyers really want to judge is: whether you are a stable supplier of a specific product category.

Mistake 4: Underestimating the impact of “information expressiveness”

Many Chinese companies have strong manufacturing capabilities but lack expressive power:

– Incomplete parameters
– Unclear structure
– Ambiguous product logic

👉 The result is that buyers leave before they even see your true capability.

IV. Correct Understanding: The Future is “Reshaping Division of Labor”, Not “Who Replaces Whom”

China’s strengths lie in upstream manufacturing capacity and industrial depth, including:

– Integrated support for KSM/intermediates/API
– Large-scale manufacturing
– Delivery efficiency
– Cost control
– Wide range of categories

India’s strengths are stronger in formulations, registration experience, and undertaking global generic drug business, including:

– Experience in overseas market access
– Foundation for generic drug exports
– International formulation supply status
– Strengthening CDMO/API manufacturing capabilities

Therefore, the future is more likely to see:
China remains an important supplier for many APIs and intermediates, while India continues to strengthen its formulation, outsourcing, and part of its upstream substitution capabilities. The two are not a simple substitution relationship, but coexistence with deep coupling in competition.

What truly matters for Chinese enterprises is not anxiety, but seeing clearly:

– What will buyers value more in the future?
– Which shortboards should Chinese enterprises complement?
– What image should you present to buyers?

V. Practical Suggestions: How Should Chinese API Companies Adjust?

1. Shift from “Price-based Suppliers” to “Capability Suppliers”

Do not only make buyers remember your price, but let them understand:
your stable capability in a specific product category.

2. Strengthen “Product Structure Expression”

More important than a single product is:

– Product system
– Product logic
– Application directions

👉 Help buyers quickly understand your positioning.

3. Improve the “Judgability” of Information

At the very least, make buyers see:

– Product name
– Key parameters
– Supply capacity

👉 Help buyers make quick decisions.

4. Establish a “Trustworthy” Website Presentation

Include:

– Complete information
– Clear logic
– Professional expression

👉 This is the basic condition for conversion.

VI. The Real Change is the “Way of Being Chosen”

India’s rise is a trend. China’s strength remains a reality. But the more important change is that the way buyers select suppliers is transforming.
In the past: 👉 Who is cheaper?
Now: 👉 Who is more stable + Who is easier to judge + Who is more trustworthy?

Many enterprises do not have orders, not because the product is bad, but because they failed to pass the buyer’s first round of screening.